Our Most Read Stories of 2022
From celiac disease drugs to long COVID to burping (well, not burping), here are the most-read CUIMC News stories in 2022:
Not every bump on a child’s body is a cause for concern: When to call your doctor and when to stay home.
A study by Columbia immunologists shows that inhaled environmental pollutants accumulate inside immune cells, eventually weakening the cells’ ability to fight respiratory infections.
Prostate cancer is the most common cancer diagnosed among men in the United States.
Based on Columbia research, an experimental drug for a rare type of ALS is in phase 3 testing.
A new ultraviolet light could reduce spread of airborne diseases indoors.
One out of four people have COVID symptoms for more than 12 weeks, with varying degrees of severity.
The primary source of vitamin D is sunlight, but between October and April in New York, the sun provides minimal or no vitamin D, regardless of time spent outdoors.
A plant-based diet is not the same as a vegetarian diet.
Drug therapy for celiac disease has evolved from a mere concept to more than a dozen candidate medications in trials with patients.
You should wait 30 minutes after eating before brushing your teeth.
For people who cannot burp, a treatment is available.